CureMatch, Inc.
Entity
Description
  • Value proposition

    AI-based Precision Medicine Decision Support for Oncology

    CureMatch is a leader in AI-based precision medicine, digital decision support solutions that support cancer treatment. Created to empower oncologists with world-class research and sophisticated AI algorithms, the CureMatch Decision Support System assists the doctor with understanding therapeutic options that are personalized to the unique molecular profile of the individual patient’s tumor.

    digital health, oncology, decision support software, AI, precision medicine, and combination therapy

  • Match Better Cancer Treatments via Genomic BioMarkers

    The CureMatch decision support system calculates and ranks combinations of genomically matched cancer treatments. Find your matched cancer treatment options. For cancer patients, oncologists, and treatment centers that want to use Precision Medicine.

    • https://www.curematch.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Nasdaq
Nasdaq
Finance, Financial Services
Nasdaq
Finance, Financial Services 		Other

24 Jan 2023


Google
Google
IT services, Software Development
Google
IT services, Software Development 		Other

25 Oct 2022


Apple
Apple
Consumer Electronics, Computers and Electronics Manufacturing
Apple
Consumer Electronics, Computers and Electronics Manufacturing 		Other

25 Oct 2022


Amazon
Amazon
IT services, Consumer Electronics, Software Development
Amazon
IT services, Consumer Electronics, Software Development 		Other

25 Jul 2018


Servier Pharmaceuticals
Servier Pharmaceuticals
Pharmaceutical, Pharmaceutical Manufacturing
Servier Pharmaceuticals
Pharmaceutical, Pharmaceutical Manufacturing 		Not capitalistic
Partnership
Not event

13 Oct 2020


Similar entities
Last news
Show all articles
Social network dynamics